Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

AI-driven decision engines and intelligent orchestration layers are crucial for navigating geopolitical risks and ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

IDMP standards aim to improve medicinal product data management but have faced delays, limiting their benefits for the life ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, Regulatory Compliance Associates (RCA), and Siegfried ...

Britton Jimenez, SVP of Sales and Marketing at Codexis, explains how the ECO Synthesis® Manufacturing Platform overcomes the ...

Dr. Eva-Maria Hempe, NVIDIA, looks back at 2025 and ahead to 2026, noting that AI accelerates pharma overall, particularly in ...

George Tidmarsh and Vinay Prasad have taken leadership roles at CDER and CBER, respectively, impacting FDA's drug and ...

In Episode 30, John Androsavich, Benjamin Fryer, and John Wilkerson go behind the headlines. Behind the Headlines examines ...

A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through ...